Table 1.
Experimental Approach |
Myelin Thickness | Myelination Degree | Phosphorylation of Downstream Elements | Myelin Proteins Expression | Nº of Mature OLs | Nº of OPCs | OL Differentiation | References |
---|---|---|---|---|---|---|---|---|
Bace1−/− | - | Normal | - | - | Normal | Normal | Normal | [39] |
Akt-DD 1 | + | + | + | + | Normal | Normal | Enhanced | [42] |
Rapamycin 2 | - | - | - | - | [45] | |||
Ptenfl/fl; Cnp1Cre/+
Ptenfl/fl; Plp1CreERT2/+ |
+ | + | Normal | Normal | [43] | |||
Ptenfl/fl; Olig2Cre/+ | + | + | + | Normal | Normal | Normal | [44] | |
CNPCre/+; Raptorfl/fl | - | - | - | - | - | + | Delayed | [46] |
CNPCre/+; Rictorfl/fl | Normal | Slightly - | - | Normal | - | Increased | [46] | |
CNPCre/+; Rptorfl/fl | - | - | - | - | Normal | Normal | [47] | |
CNPCre/+; Rictorfl/fl | - | Delayed myelination | Normal | Normal | Normal | Normal | [47] | |
CNPCre/+; Rptorfl/fl; Rictorfl/fl | - | - | - | - | - | + | Delayed | [47] |
CNPCre/+; Tsc1fl/fl | - | + | - | [47] | ||||
Olig1Cre/+; Rheb1fl/fl | Normal | - | - | - | - | + | Impaired | [50] |
NG2Cre/+; Tsc1fl/fl | + (later is normal) | Enhanced remyelination | + | Normal | Normal | Normal | [48] | |
Plp1Cre/+; Tsc1fl/fl | - (later is normal) | Delayed remyelination | Normal | Normal | [48] |
(-) indicates lower levels or numbers, (+) indicates higher levels or numbers. 1 constitutively active Akt, 2 mTOR inhibitor.